ProAssurance (PRA)
(Real Time Quote from BATS)
$13.20 USD
-0.45 (-3.30%)
Updated Apr 26, 2024 02:12 PM ET
5-Strong Sell of 5 5
D Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for ProAssurance Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,137 | 1,107 | 1,124 | 875 | 1,000 |
Cost Of Goods | 800 | 777 | 752 | 661 | 754 |
Gross Profit | 337 | 330 | 372 | 213 | 246 |
Selling & Adminstrative & Depr. & Amort Expenses | 345 | 307 | 268 | 399 | 254 |
Income After Depreciation & Amortization | -8 | 23 | 104 | -186 | -8 |
Non-Operating Income | -8 | -8 | 62 | -16 | -5 |
Interest Expense | 23 | 20 | 20 | 16 | 17 |
Pretax Income | -39 | -6 | 147 | -217 | -29 |
Income Taxes | -1 | -6 | 2 | -41 | -30 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -39 | 0 | 144 | -176 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -39 | 0 | 144 | -176 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 62 | 61 | 141 | -3 | 11 |
Depreciation & Amortization (Cash Flow) | 70 | 38 | 37 | 182 | 19 |
Income After Depreciation & Amortization | -8 | 23 | 104 | -186 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 52.79 | 54.14 | 54.06 | 53.91 | 53.84 |
Diluted EPS Before Non-Recurring Items | -0.14 | 0.45 | 1.40 | -0.52 | -0.81 |
Diluted Net EPS (GAAP) | -0.73 | -0.01 | 2.67 | -3.26 | 0.02 |
Fiscal Year end for ProAssurance Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 296.96 | 275.75 | 291.83 | 272.68 |
Cost Of Goods | NA | 195.25 | 208.89 | 191.06 | 205.30 |
Gross Profit | NA | 101.71 | 66.86 | 100.77 | 67.38 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 81.97 | 118.12 | 76.98 | 67.79 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 19.74 | -51.26 | 23.79 | -0.41 |
Non-Operating Income | NA | -3.34 | 2.69 | -4.74 | -2.47 |
Interest Expense | NA | 6.67 | 5.51 | 5.50 | 5.46 |
Pretax Income | NA | 9.73 | -54.09 | 13.55 | -8.35 |
Income Taxes | NA | 3.36 | -4.66 | 2.93 | -2.17 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 6.38 | -49.43 | 10.63 | -6.17 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 6.38 | -49.43 | 10.63 | -6.17 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 51.15 | 52.01 | 53.92 | 54.12 |
Diluted EPS Before Non-Recurring Items | NA | -0.05 | -0.07 | 0.16 | -0.15 |
Diluted Net EPS (GAAP) | NA | 0.13 | -0.95 | 0.20 | -0.11 |